# Kelly G. Knupp

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kelly-g-knupp/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,559 |
| Field | Epilepsy research and treatment |
| h-index | 36 |
| i10-index | 72 |
| Last Known Institution | Children's Hospital Colorado |
| OpenAlex ID | https://openalex.org/A5031681045 |
| ORCID iD | 0000-0002-1967-0827 |
| Works | 138 |

## Researcher papers

- [Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/fenfluramine-hydrochloride-for-the-treatment-of-seizures-in-dravet-syndrome-a/)
- [Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel](https://scholariq.org/papers/optimizing-the-diagnosis-and-management-of-dravet-syndrome-recommendations-from/)
- [Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens](https://scholariq.org/papers/fenfluramine-for-treatment-resistant-seizures-in-patients-with-dravet-syndrome/)
- [Response to treatment in a prospective national infantile spasms cohort](https://scholariq.org/papers/response-to-treatment-in-a-prospective-national-infantile-spasms-cohort/)
- [Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome](https://scholariq.org/papers/clemizole-and-modulators-of-serotonin-signalling-suppress-seizures-in-dravet/)
- [International consensus on diagnosis and management of Dravet syndrome](https://scholariq.org/papers/international-consensus-on-diagnosis-and-management-of-dravet-syndrome/)
- [Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy](https://scholariq.org/papers/parental-reporting-of-response-to-oral-cannabis-extracts-for-treatment-of/)
- [Early-Life Epilepsies and the Emerging Role of Genetic Testing](https://scholariq.org/papers/early-life-epilepsies-and-the-emerging-role-of-genetic-testing/)
- [Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome](https://scholariq.org/papers/efficacy-and-safety-of-fenfluramine-for-the-treatment-of-seizures-associated/)
- [Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability](https://scholariq.org/papers/heterozygous-hnrnpu-variants-cause-early-onset-epilepsy-and-severe-intellectual/)
- [Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome](https://scholariq.org/papers/fenfluramine-increases-seizure-free-days-in-patients-with-lennox-gastaut/)

## Researcher topics

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Neonatal and fetal brain pathology](https://scholariq.org/topics/neonatal-and-fetal-brain-pathology/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)

## Researcher university

- [Children's Hospital Colorado](https://scholariq.org/institutions/children-s-hospital-colorado/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.